|Articles|February 9, 2022
- Pharmaceutical Executive-02-01-2022
- Volume 42
- Issue 2
Pharmaceutical Executive, February 2022 Issue (PDF)
Advertisement
Articles in this issue
over 4 years ago
As Change Continues, Are You Digitally Fit For the Future?over 4 years ago
Ready for Pharma’s Next Chapterover 4 years ago
The Tech Perspective: Coordinating a Plan of Engagementover 4 years ago
The Importance of Culturally Inclusive and Relevant Marketingover 4 years ago
Messaging Makeoverover 4 years ago
Ethics of Antibioticsover 4 years ago
What’s Up in Biotech These Days? Not Much, Unfortunatelyover 4 years ago
Planning for Second to Market in Orphan Disease Spaceover 4 years ago
AI and Analytics Appear Ready to Surge in Sales and Marketingover 4 years ago
It’s Time for Companies To See Employees as Full-Time PeopleAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant
2
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
3
WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain
4
FDA's Timeline for DTC Prescription Drug Ad Oversight
5